UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study

The lancet oncology, 2021-07, Vol.22 (7), p.919-930

2021

Volltextzugriff (PDF)

A 3D-2D Hybrid U-Net Convolutional Neural Network Approach to Prostate Organ Segmentation of Multiparametric MRI

American journal of roentgenology (1976), 2021-01, Vol.216 (1), p.111-116

2021

Volltextzugriff (PDF)

Development and Validation of a Novel Integrated Clinical-Genomic Risk Group Classification for Localized Prostate Cancer

Journal of clinical oncology, 2018-02, Vol.36 (6), p.581-590

2018

Volltextzugriff (PDF)

A phase II study of docetaxel plus lycopene in metastatic castrate resistant prostate cancer

Biomedicine & pharmacotherapy, 2021-11, Vol.143, p.112226-112226, Article 112226

2021

Volltextzugriff (PDF)

Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial

Nature medicine, 2024-08, Vol.30 (8), p.2216-2223

2024

Volltextzugriff (PDF)

Publisher Correction: Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial

Nature medicine, 2024-08, Vol.30 (8), p.2377-2377

2024

Volltextzugriff (PDF)

Author Correction: Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial

Nature medicine, 2024-08, Vol.30 (8), p.2372-2372

2024

Volltextzugriff (PDF)

Kavalactone Kawain Impedes Urothelial Tumorigenesis in UPII-Mutant Ha-Ras Mice via Inhibition of mTOR Signaling and Alteration of Cancer Metabolism

Molecules (Basel, Switzerland), 2023-02, Vol.28 (4), p.1666

2023

Volltextzugriff (PDF)

Use of immunotherapy in clinical management of genitourinary cancers – a review

Cancer treatment and research communications, 2022, Vol.31, p.100564-100564, Article 100564

2022

Volltextzugriff (PDF)

Effects of androgen deprivation on cerebral morphometry in prostate cancer patients--an exploratory study

PloS one, 2013-08, Vol.8 (8), p.e72032

2013

Volltextzugriff (PDF)

Utility of quantitative apparent diffusion coefficient measurements and normalized apparent diffusion coefficient ratios in the diagnosis of clinically significant peripheral zone prostate cancer

British journal of radiology, 2018-07, Vol.91 (1088), p.20180091-20180091

2018

Volltextzugriff (PDF)

Chemoprevention of Urothelial Cell Carcinoma Tumorigenesis by Dietary Flavokawain A in UPII-Mutant Ha-ras Transgenic Mice

Pharmaceutics, 2022-02, Vol.14 (3), p.496

2022

Volltextzugriff (PDF)

Management of Advanced Prostate Cancer in Clinical Practice: Real-World Answers to Challenging Dilemmas

JCO oncology practice, 2020-12, Vol.16 (12), p.783-789

2020

Volltextzugriff (PDF)

Comparison of Perioperative Outcomes for Radical Nephrectomy Based on Surgical Approach for Masses Greater Than 10 cm

Journal of endourology, 2021-12, Vol.35 (12), p.1785-1792

2021

Volltextzugriff (PDF)

Flavokawain A Reduces Tumor-Initiating Properties and Stemness of Prostate Cancer

Frontiers in oncology, 2022-07, Vol.12, p.943846-943846

2022

Volltextzugriff (PDF)

‘Race’ and Prostate Cancer Mortality in Equal-access Healthcare Systems

The American journal of medicine, 2013-12, Vol.126 (12), p.1084-1088

2013

Volltextzugriff (PDF)

Impact of Clinical Factors on 18F-Flotufolastat Detection Rates in Men With Recurrent Prostate Cancer: Exploratory Analysis of the Phase 3 SPOTLIGHT Study

Advances in radiation oncology, 2024-08, Vol.9 (8), p.101532, Article 101532

2024

Volltextzugriff (PDF)

Flavokawain B targets protein neddylation for enhancing the anti-prostate cancer effect of Bortezomib via Skp2 degradation

Cell communication and signaling, 2019-03, Vol.17 (1), p.25-25, Article 25

2019

Volltextzugriff (PDF)

Effects of androgen deprivation on brain function in prostate cancer patients - a prospective observational cohort analysis

BMC cancer, 2012-08, Vol.12 (1), p.371-371, Article 371

2012

Volltextzugriff (PDF)

Impact of Clinical Factors on 18 F-Flotufolastat Detection Rates in Men With Recurrent Prostate Cancer: Exploratory Analysis of the Phase 3 SPOTLIGHT Study

Advances in radiation oncology, 2024-08, Vol.9 (8), p.101532

2024

Volltextzugriff (PDF)

Kawain Inhibits Urinary Bladder Carcinogenesis through Epigenetic Inhibition of LSD1 and Upregulation of H3K4 Methylation

Biomolecules (Basel, Switzerland), 2023-03, Vol.13 (3), p.521

2023

Volltextzugriff (PDF)

1 – 25 von 139

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(134)
Mit Volltextzugriff
(79)

Publikationsform

Artikel
(139)

Sprache

Englisch
(139)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study

Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial

A 3D-2D Hybrid U-Net Convolutional Neural Network Approach to Prostate Organ Segmentation of Multiparametric MRI

Development and Validation of a Novel Integrated Clinical-Genomic Risk Group Classification for Localized Prostate Cancer

Predictors of Recurrence, and Progression-Free and Overall Survival following Open versus Robotic Radical Cystectomy: Analysis from the RAZOR Trial with a 3-Year Followup

A phase II study of docetaxel plus lycopene in metastatic castrate resistant prostate cancer

Pembrolizumab monotherapy for high-risk non-muscle-invasive bladder cancer without carcinoma in situ and unresponsive to BCG (KEYNOTE-057): a single-arm, multicentre, phase 2 trial

Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial

Publisher Correction: Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial

Author Correction: Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial

Kavalactone Kawain Impedes Urothelial Tumorigenesis in UPII-Mutant Ha-Ras Mice via Inhibition of mTOR Signaling and Alteration of Cancer Metabolism

Use of immunotherapy in clinical management of genitourinary cancers – a review

Effects of androgen deprivation on cerebral morphometry in prostate cancer patients--an exploratory study

Utility of quantitative apparent diffusion coefficient measurements and normalized apparent diffusion coefficient ratios in the diagnosis of clinically significant peripheral zone prostate cancer

Chemoprevention of Urothelial Cell Carcinoma Tumorigenesis by Dietary Flavokawain A in UPII-Mutant Ha-ras Transgenic Mice

Management of Advanced Prostate Cancer in Clinical Practice: Real-World Answers to Challenging Dilemmas

Comparison of Perioperative Outcomes for Radical Nephrectomy Based on Surgical Approach for Masses Greater Than 10 cm

Flavokawain A Reduces Tumor-Initiating Properties and Stemness of Prostate Cancer

‘Race’ and Prostate Cancer Mortality in Equal-access Healthcare Systems

Impact of Clinical Factors on 18F-Flotufolastat Detection Rates in Men With Recurrent Prostate Cancer: Exploratory Analysis of the Phase 3 SPOTLIGHT Study

Flavokawain B targets protein neddylation for enhancing the anti-prostate cancer effect of Bortezomib via Skp2 degradation

A Description and Safety Overview of Irreversible Electroporation for Prostate Tissue Ablation in Intermediate-Risk Prostate Cancer Patients: Preliminary Results from the PRESERVE Trial

Effects of androgen deprivation on brain function in prostate cancer patients - a prospective observational cohort analysis

Impact of Clinical Factors on 18 F-Flotufolastat Detection Rates in Men With Recurrent Prostate Cancer: Exploratory Analysis of the Phase 3 SPOTLIGHT Study

Kawain Inhibits Urinary Bladder Carcinogenesis through Epigenetic Inhibition of LSD1 and Upregulation of H3K4 Methylation

Suchergebnisse filtern